Medicamen Biotech Limited (NSE:MEDICAMEQ) — Stock Price

Rs236.45 INR
▲ 0.32% today

Medicamen Biotech Limited (NSE:MEDICAMEQ) is currently trading at Rs236.45 INR, up 0.32% today. Over the past 52 weeks, shares have ranged between Rs223.30 and Rs415.95. This page tracks Medicamen Biotech Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Medicamen Biotech Limited market cap and net worth.

Medicamen Biotech Limited (MEDICAMEQ) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Medicamen Biotech Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Medicamen Biotech Limited Income Statement — Revenue, Profit & Earnings by Year

Medicamen Biotech Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs1.63 Billion Rs1.79 Billion Rs1.41 Billion Rs1.15 Billion Rs1.13 Billion
Cost of Revenue Rs1.24 Billion Rs941.05 Million Rs720.93 Million Rs674.58 Million Rs792.00 Million
Gross Profit Rs389.90 Million Rs852.01 Million Rs687.74 Million Rs479.88 Million Rs335.16 Million
Research & Development — — Rs14.11 Million Rs10.51 Million Rs6.86 Million
SG&A Rs69.25 Million Rs66.78 Million Rs43.82 Million Rs44.83 Million Rs35.57 Million
Total Operating Expenses Rs321.98 Million Rs335.17 Million Rs91.99 Million Rs289.89 Million Rs160.41 Million
Operating Income Rs67.92 Million Rs516.84 Million Rs182.46 Million Rs187.07 Million Rs174.96 Million
EBITDA Rs201.02 Million Rs245.66 Million Rs277.12 Million Rs258.07 Million Rs204.25 Million
EBIT Rs130.36 Million Rs174.73 Million Rs204.37 Million Rs200.35 Million Rs179.06 Million
Interest Expense Rs31.56 Million Rs43.97 Million Rs33.92 Million Rs19.41 Million Rs15.12 Million
Income Before Tax Rs98.80 Million Rs130.76 Million Rs170.45 Million Rs180.94 Million Rs163.94 Million
Income Tax Expense Rs33.24 Million Rs35.82 Million Rs23.16 Million Rs31.97 Million Rs42.65 Million
Net Income Rs71.08 Million Rs109.31 Million Rs148.44 Million Rs148.98 Million Rs121.29 Million

Medicamen Biotech Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Medicamen Biotech Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs2.97 Billion Rs2.95 Billion Rs2.79 Billion Rs2.26 Billion Rs1.94 Billion
Total Current Assets Rs1.65 Billion Rs1.60 Billion Rs1.63 Billion Rs1.23 Billion Rs960.33 Million
Cash & Equivalents — — — — —
Short-term Investments Rs29.49 Million Rs139.20 Million Rs181.86 Million Rs29.89 Million Rs361.20K
Net Receivables Rs689.00 Million Rs552.59 Million Rs652.58 Million Rs632.24 Million Rs525.47 Million
Inventory Rs621.37 Million Rs593.75 Million Rs450.57 Million Rs270.10 Million Rs52.04 Million
Property, Plant & Equipment — — Rs917.59 Million Rs921.17 Million Rs894.35 Million
Goodwill — — — — Rs0.00
Total Liabilities Rs841.04 Million Rs875.67 Million Rs851.03 Million Rs792.24 Million Rs611.18 Million
Total Current Liabilities Rs781.65 Million Rs845.55 Million Rs825.74 Million Rs726.91 Million Rs532.74 Million
Long-term Debt Rs37.34 Million Rs12.55 Million Rs8.70 Million Rs50.74 Million Rs64.05 Million
Net Debt Rs294.94 Million Rs163.26 Million Rs34.04 Million Rs219.71 Million Rs171.63 Million
Total Stockholder Equity Rs2.13 Billion Rs2.07 Billion Rs1.93 Billion Rs1.46 Billion Rs1.33 Billion
Retained Earnings Rs963.08 Million Rs907.67 Million Rs823.35 Million Rs687.82 Million Rs551.07 Million

Medicamen Biotech Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Medicamen Biotech Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs-98.59 Million Rs-67.44 Million Rs-62.93 Million Rs41.09 Million Rs127.72 Million
Capital Expenditures Rs20.73 Million Rs62.87 Million Rs66.01 Million Rs86.08 Million Rs179.66 Million
Free Cash Flow Rs-119.32 Million Rs-130.31 Million Rs-128.94 Million Rs-44.99 Million Rs-51.94 Million
Investing Cash Flow Rs-23.78 Million Rs-55.63 Million Rs-58.80 Million Rs-84.73 Million Rs-178.13 Million
Financing Cash Flow Rs12.16 Million Rs63.13 Million Rs291.27 Million Rs42.98 Million Rs58.39 Million
Dividends Paid Rs-12.71 Million Rs-12.65 Million Rs12.65 Million Rs12.22 Million Rs6.11 Million
Stock-Based Compensation — — Rs13.83 Million Rs7.80 Million Rs-1.19 Million
Depreciation Rs70.66 Million Rs70.93 Million Rs63.67 Million Rs57.71 Million Rs25.20 Million
Change in Cash Rs28.94 Million Rs-59.93 Million Rs169.54 Million Rs-658.30K Rs7.98 Million

Medicamen Biotech Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Medicamen Biotech Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Feb 09, 2026 — — —
Nov 12, 2025 — — —
Aug 11, 2025 — — —
Feb 10, 2025 — — —
Nov 08, 2024 — — —